Last Call for Med-e-Tel 2010 Early Bird Registration

14-16 April 2010, Luxembourg.
The Med-e-Tel forum is the ideal opportunity to follow up on the latest developments and initiatives in Telemedicine and eHealth and to exchange ideas and experiences related to ICT applications in healthcare. Register on or before Monday, 15th March, 2010 and get the early bird rate for your Med-e-Tel registration. This is a savings of 25% on the full registration fee, a full package offering you access to all Med-e-Tel conference sessions, expo and networking area, breaks, lunches, receptions, conference materials and wifi access at the conference venue.

Hear from the following speakers at the Med-e-Tel opening on Wednesday April 14th:

  • Mars Di Bartolomeo, Minister of Health, Luxembourg
  • Michael Nerlich, President, ISfTeH
  • Yunkap Kwankam, Executive Director, ISfTeH
  • Karl Brown, Associate Director, Rockefeller Foundation
  • Gérard Comyn, Former Head, ICT for Health, European Commission and Vice-President, CATEL
  • Peter Waegemann, Vice-President, mHealth Initiative
  • Joseph Dal Molin, President, e-cology and Director, WorldVistA
  • Tim Ellis, Programme Manager, Whole System Demonstrators, UK Dept. of Health
  • Günter Schreier, Head, Information Management & eHealth, Austrian Institute of Technology
  • Brenda Wiederhold, Secretary General, International Association for CyberTherapy, Training and Rehabilitation

And more keynote addresses at the Thursday April 15th plenary:

  • Valery Stolyar, Secretary, Russian Telemedicine Association
  • Feng Zhao, eHealth Coordinator/Senior Health Specialist, The World Bank
  • David Benton, CEO, International Council of Nurses
  • Mark Blatt, Global Director Health Industry Solutions, Digital Health Group, Intel

An extensive three day conference program with sessions on:

  • Benefits of Free/Libre Open Source Software in Health Care (FLOSS-HC)
  • Clinical Telemedicine Course
  • Closing the Healthcare Gap in Developing Countries
  • Cost Effectiveness
  • E-Mental Health: Enhancing Mental Health Services Through Information and Communication Technology
  • eLearning
  • Electronic Health Records
  • Ethics and Acceptance
  • Framework for Development of International Quality Standards for Teleconsultation Centers (Advisory Committee Meeting)
  • HHR for eHealth: What Needs, What Options, What Solutions?
  • Home Care and Assisted Living
  • Improving Electronic Care Record Keeping, Boosting Productivity, Accountability and Quality of Social Care
  • International Telemedicine and eHealth Initiatives and Developments
  • Medical Informatics
  • Mobile Health
  • New Models of Care and the Use of New ICT Solutions
  • Standardization and eHealth
  • Telecardiology
  • Teleconsultations and Remote Treatment
  • Telemonitoring
  • Telenursing
  • Telesurgery and Wound Care
  • Virtual Reality and Rehabilitation

For further information and registration, please visit:
http://www.medetel.eu

About Med-e-Tel
Med-e-Tel focuses on ehealth and telemedicine applications and a wide range of other medical ICT applications and on the convergence of information and communication technology with medical applications, which lead to higher quality of care, cost reductions, workflow efficiency, and widespread availability of healthcare services.

The "Med" in Med-e-Tel stands for healthcare services (institutional and home based care, prevention and education) and for medical products and equipment (medical imaging equipment, monitoring devices, electronic health records, etc.).
The "e" stands for the electronic and IT industry and services (hard- & software, internet, e-mail, etc.).
The "Tel" stands for telecommunications (whether it is POTS, ISDN, wireless, satellite, videoconferencing, VoIP, or other).

For further information, please visit www.medetel.eu.

Most Popular Now

Pfizer receives positive FDA Advisory Committee vo…

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that avail...

Engineered bacteria find tumors, then alert the au…

Combining discoveries in cancer immunology with sophisticated genetic engineering, Columbia University researchers have created a sort of "bacterial suicide squad" that ...

First nasal monoclonal antibody treatment for COVI…

A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the ...

US FDA Advisory Committee votes to support effecti…

GSK plc (LSE/NYSE: GSK) announced that the US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that the avail...

"Semantic similarity" leads to novel dru…

The words that researchers use to describe their results can be harnessed to discover potential new treatments for Parkinson's disease, according to a new study published...

Tumour cells' response to chemotherapy is driven b…

Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research led by the...

Pfizer's ZAVZPRET™ (zavegepant) migraine nasal spr…

Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptid...

Pfizer invests $43 billion to battle cancer

Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a...

Gene and cell therapies to combat pancreatic cance…

Pancreatic cancer is an incurable form of cancer, and gene therapies are currently in clinical testing to treat this deadly disease. A comprehensive review of the gene an...

Scientists reveal a potential new approach to trea…

Scientists at the National Institutes of Health and Massachusetts General Hospital in Boston have uncovered a potential new approach against liver cancer that could lead ...

Normalizing tumor blood vessels may improve immuno…

A type of immune therapy called chimeric antigen receptor (CAR)-T cell therapy has revolutionized the treatment of multiple types of blood cancers but has shown limited e...

Digital twin opens way to effective treatment of i…

Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently...